| USD millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.5 | 48.9 | 57.3 | 54.8 | 63.1 | 61.7 | −2.2% | |
| Cost of revenue | 0.2 | 0.0 | 0.0 | 0.0 | 8.3 | 7.9 | −5.1% | |
| Gross profit | 14.2 | 48.9 | 57.3 | 54.8 | 54.8 | 53.9 | −1.8% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Selling, general & administrative | 1.6 | 4.0 | 6.7 | 8.4 | 8.7 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 1.6 | 48.9 | 57.3 | 54.8 | 18.8 | — | — | |
| Operating income | 12.7 | 0.0 | 0.0 | 0.0 | 36.0 | 37.2 | +3.4% | |
| Interest expense | 0.1 | 2.6 | 5.8 | 7.2 | 7.5 | 7.4 | −1.4% | |
| Interest income | 10,749.5 | 51.5 | 62.9 | 62.1 | 62.9 | 61.7 | −1.9% | |
| Other income / expense | 0.0 | 32.3 | 38.7 | 37.0 | 0.0 | — | — | |
| Pre-tax income | 12.7 | 32.3 | 38.7 | 37.0 | 36.0 | 29.4 | −18.3% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | 12.7 | 32.3 | 38.7 | 37.0 | 36.0 | 29.4 | −18.3% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | 0.54 | 1.83 | 2.14 | 1.92 | 1.71 | 1.39 | −18.9% | |
| EPS, diluted (per share) | 0.54 | 1.82 | 2.11 | 1.88 | 1.68 | 1.37 | −18.5% | |
| EBITDA | 0.1 | 563.5 | 0.0 | 0.0 | 36.0 | 38.4 | +6.8% | |
| Depreciation & amortization | 0.1 | 563.5 | 0.0 | 0.0 | 0.0 | — | — | |
| Weighted average shares (shares) | 17,453,553 | 17,653,765 | 18,085,088 | 19,280,000 | 21,004,000 | — | — | |
| Weighted average diluted shares (shares) | 17,453,553 | 17,746,214 | 18,343,725 | 19,714,000 | 21,432,000 | — | — | |
| Gross margin | 98.5% | 100.0% | 100.0% | 100.0% | 86.9% | 87.3% | +0.4 pts | |
| Operating margin | 87.5% | 0.0% | 0.0% | 0.0% | 57.1% | 60.3% | +3.3 pts | |
| Net margin | 87.5% | 66.1% | 67.5% | 67.6% | 57.1% | 47.7% | −9.4 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
